{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:22:09Z","timestamp":1740122529534,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"national center for advancing translational sciences","doi-asserted-by":"publisher","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11239-021-02552-x","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T13:03:50Z","timestamp":1629378230000},"page":"446-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19"],"prefix":"10.1007","volume":"53","author":[{"given":"Julie E.","family":"Farrar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-4045","authenticated-orcid":false,"given":"Toby C.","family":"Trujillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott W.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyra","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Hassell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyree H.","family":"Kiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,19]]},"reference":[{"key":"2552_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMP, Kant KM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145\u2013147","journal-title":"Thromb Res"},{"issue":"6","key":"2552_CR2","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46(6):1089\u20131098","journal-title":"Intensive Care Med"},{"issue":"2","key":"2552_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","volume":"142","author":"L Zhang","year":"2020","unstructured":"Zhang L, Feng X, Zhang D, Jiang C, Mei H, Wang J et al (2020) Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome. Circulation 142(2):114\u2013128","journal-title":"Circulation"},{"issue":"Suppl 1","key":"2552_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/ijlh.13230","volume":"42","author":"R Beun","year":"2020","unstructured":"Beun R, Kusadasi N, Sikma M, Westerink J, Huisman A (2020) Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2. Int J Lab Hematol 42(Suppl 1):19\u201320","journal-title":"Int J Lab Hematol"},{"issue":"9","key":"2552_CR5","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1097\/CCM.0000000000004466","volume":"48","author":"TK Maatman","year":"2020","unstructured":"Maatman TK, Jalali F, Feizpour C, Douglas A, McGuire SP, Kinnaman G et al (2020) Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019. Crit Care Med 48(9):e783\u2013e790","journal-title":"Crit Care Med"},{"issue":"3","key":"2552_CR6","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1111\/bjh.16908","volume":"190","author":"JA Hippensteel","year":"2020","unstructured":"Hippensteel JA, Burnham EL, Jolley SE (2020) Prevalence of venous thromboembolism in critically ill patients with COVID-19. Br J Haematol 190(3):e134\u2013e137","journal-title":"Br J Haematol"},{"key":"2552_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.thromres.2020.05.018","volume":"192","author":"P Demelo-Rodr\u00edguez","year":"2020","unstructured":"Demelo-Rodr\u00edguez P, Cervilla-Mu\u00f1oz E, Ordieres-Ortega L, Parra-Virto A, Toledano-Mac\u00edas M, Toledo-Samaniego N et al (2020) Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res 192:23\u201326","journal-title":"Thromb Res"},{"issue":"1","key":"2552_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.01201-2020","volume":"56","author":"M Criel","year":"2020","unstructured":"Criel M, Falter M, Jaeken J, Van Kerrebroeck M, Lefere I, Meylaerts L et al (2020) Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it? Eur Respir J 56(1):1","journal-title":"Eur Respir J"},{"issue":"16","key":"2552_CR9","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.jacc.2020.08.041","volume":"76","author":"GN Nadkarni","year":"2020","unstructured":"Nadkarni GN, Lala A, Bagiella E, Chang HL, Moreno PR, Pujadas E et al (2020) Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J Am Coll Cardiol 76(16):1815\u20131826","journal-title":"J Am Coll Cardiol"},{"key":"2552_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s11239-021-02394-7","volume":"51","author":"WJ Jenner","year":"2021","unstructured":"Jenner WJ, Kanji R, Mirsadraee S, Gue YX, Price S, Prasad S et al (2021) Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review. J Thromb Thrombol 51:595\u2013607","journal-title":"J Thromb Thrombol"},{"issue":"11","key":"2552_CR11","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","volume":"8","author":"S Barbar","year":"2010","unstructured":"Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8(11):2450\u20132457","journal-title":"J Thromb Haemost"},{"issue":"14","key":"2552_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa1014475","volume":"364","author":"D Cook","year":"2011","unstructured":"Cook D, Meade M, Guyatt G, Walter S, Heels-Ansdell D, Warkentin TE et al (2011) Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 364(14):1305\u20131314","journal-title":"N Engl J Med"},{"issue":"7","key":"2552_CR13","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","volume":"58","author":"H Han","year":"2020","unstructured":"Han H, Yang L, Liu R, Liu F, Wu KL, Li J et al (2020) Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 58(7):1116\u20131120","journal-title":"Clin Chem Lab Med"},{"key":"2552_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ajh.26102","volume":"96","author":"ML Meizlish","year":"2021","unstructured":"Meizlish ML, Goshua G, Liu Y, Fine R, Amin K, Chang E et al (2021) Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis. Am J Hematol 96:471\u2013479","journal-title":"Am J Hematol"},{"issue":"5","key":"2552_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18(5):1094\u20131099","journal-title":"J Thromb Haemost"},{"key":"2552_CR16","doi-asserted-by":"publisher","first-page":"622","DOI":"10.7326\/M20-6739","volume":"174","author":"H Al-Samkari","year":"2021","unstructured":"Al-Samkari H, Gupta S, Leaf RK, Wang W, Rosovsky RP, Brenner SK et al (2021) Thrombosis, bleeding, and the observational effect of early therapeutic anticoagulation on survival in critically ill patients with COVID-19. Ann Intern Med 174:622\u2013632","journal-title":"Ann Intern Med"},{"issue":"6","key":"2552_CR17","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1055\/s-0040-1710018","volume":"120","author":"L Spiezia","year":"2020","unstructured":"Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E et al (2020) COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost 120(6):998\u20131000","journal-title":"Thromb Haemost"},{"issue":"7","key":"2552_CR18","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jth.14850","volume":"18","author":"M Panigada","year":"2020","unstructured":"Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V et al (2020) Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 18(7):1738\u20131742","journal-title":"J Thromb Haemost"},{"key":"2552_CR19","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fphar.2020.01124","volume":"11","author":"P Paolisso","year":"2020","unstructured":"Paolisso P, Bergamaschi L, D\u2019Angelo EC, Donati F, Giannella M, Tedeschi S et al (2020) Preliminary experience with low molecular weight heparin strategy in COVID-19 patients. Front Pharmacol 11:1124","journal-title":"Front Pharmacol"},{"key":"2552_CR20","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1001\/jama.2021.4152","volume":"325","author":"P Sadeghipour","year":"2021","unstructured":"Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M et al (2021) Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION Randomized Clinical Trial. JAMA 325:1620\u20131630","journal-title":"JAMA"},{"issue":"1","key":"2552_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","volume":"76","author":"I Paranjpe","year":"2020","unstructured":"Paranjpe I, Fuster V, Lala A, Russak AJ, Glicksberg BS, Levin MA et al (2020) Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol 76(1):122\u2013124","journal-title":"J Am Coll Cardiol"},{"key":"2552_CR22","unstructured":"NIH. Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients: National Institutes of Health; 2021 https:\/\/www.nih.gov\/news-events\/news-releases\/full-dose-blood-thinners-decreased-need-life-support-improved-outcome-hospitalized-covid-19-patients"},{"issue":"6","key":"2552_CR23","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1055\/s-0040-1710019","volume":"120","author":"Z Zhai","year":"2020","unstructured":"Zhai Z, Li C, Chen Y, Gerotziafas G, Zhang Z, Wan J et al (2020) Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines. Thromb Haemost 120(6):937\u2013948","journal-title":"Thromb Haemost"},{"issue":"3","key":"2552_CR24","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.chest.2020.05.559","volume":"158","author":"LK Moores","year":"2020","unstructured":"Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K et al (2020) Prevention, diagnosis, and treatment of vte in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest 158(3):1143\u20131163","journal-title":"Chest"},{"issue":"1","key":"2552_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11239-020-02138-z","volume":"50","author":"GD Barnes","year":"2020","unstructured":"Barnes GD, Burnett A, Allen A, Blumenstein M, Clark NP, Cuker A et al (2020) Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombol 50(1):72\u201381","journal-title":"J Thromb Thrombol"},{"issue":"8","key":"2552_CR26","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/jth.14929","volume":"18","author":"AC Spyropoulos","year":"2020","unstructured":"Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T et al (2020) Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost 18(8):1859\u20131865","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2552_CR27","first-page":"167","volume":"18","author":"M Marietta","year":"2020","unstructured":"Marietta M, Ageno W, Artoni A, De Candia E, Gresele P, Marchetti M et al (2020) COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus 18(3):167\u2013169","journal-title":"Blood Transfus"},{"issue":"3","key":"2552_CR28","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","volume":"5","author":"A Cuker","year":"2021","unstructured":"Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K et al (2021) American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv 5(3):872\u2013888","journal-title":"Blood Adv"},{"issue":"2","key":"2552_CR29","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31","journal-title":"Crit Care"},{"issue":"4","key":"2552_CR30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3(4):692\u2013694","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2552_CR31","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","volume":"20","author":"T Brott","year":"1989","unstructured":"Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864\u2013870","journal-title":"Stroke"},{"issue":"24","key":"2552_CR32","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"Group NIoNDaSr-PSS","year":"1995","unstructured":"Group NIoNDaSr-PSS (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581\u20131587","journal-title":"N Engl J Med"},{"issue":"7","key":"2552_CR33","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ajh.25829","volume":"95","author":"E Terpos","year":"2020","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M et al (2020) Hematological findings and complications of COVID-19. Am J Hematol 95(7):834\u2013847","journal-title":"Am J Hematol"},{"issue":"7","key":"2552_CR34","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1111\/jth.14849","volume":"18","author":"JM Connors","year":"2020","unstructured":"Connors JM, Levy JH (2020) Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost 18(7):1559\u20131561","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02552-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-021-02552-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02552-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T06:09:51Z","timestamp":1646719791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-021-02552-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,19]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["2552"],"URL":"https:\/\/doi.org\/10.1007\/s11239-021-02552-x","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2021,8,19]]},"assertion":[{"value":"5 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Exempt status obtained from Colorado Multiple Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}